2009
DOI: 10.2147/ijn.s4937
|View full text |Cite
|
Sign up to set email alerts
|

Nanomedicine in pulmonary delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
285
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 409 publications
(290 citation statements)
references
References 229 publications
(210 reference statements)
5
285
0
Order By: Relevance
“…The human lung adenocarcinoma epithelial cell line A549 is a valuable in vitro model of human alveolar epithelial type 2 cells [15]. This cell line has been widely utilized in the studies of alveolar epithelium function [16] and drug delivery via the lung route [17]. The HEL 12469 cells are human diploid (embryo) lung fibroblasts; these cells were used as a model of normal (healthy) tissue.…”
mentioning
confidence: 99%
“…The human lung adenocarcinoma epithelial cell line A549 is a valuable in vitro model of human alveolar epithelial type 2 cells [15]. This cell line has been widely utilized in the studies of alveolar epithelium function [16] and drug delivery via the lung route [17]. The HEL 12469 cells are human diploid (embryo) lung fibroblasts; these cells were used as a model of normal (healthy) tissue.…”
mentioning
confidence: 99%
“…(27) The potential for nanomedicine to improve patient compliance and reduce side effects using respirable particles as drug carriers has made the lung an attractive target for both pulmonary and systemic pharmaceutical delivery. (31)(32)(33) The lung provides a relatively noninvasive route for inspirable drugs, among other advantages including a large surface area to deliver sustainable drug doses and achieve a relatively uniform drug distribution at the alveolar-capillary boundary. (32) For therapeutics to be distributed systemically by respirable particles, the intrinsic defense systems of the FIG.…”
Section: Discussionmentioning
confidence: 99%
“…(31)(32)(33) The lung provides a relatively noninvasive route for inspirable drugs, among other advantages including a large surface area to deliver sustainable drug doses and achieve a relatively uniform drug distribution at the alveolar-capillary boundary. (32) For therapeutics to be distributed systemically by respirable particles, the intrinsic defense systems of the FIG. 5.…”
Section: Discussionmentioning
confidence: 99%
“…Another unique property of NPs is the tendency to be phagocytized by alveolar macrophages, if they are in the range of 500–3000 nm [75,76]. The simultaneous effects, of NPs uptake and release, were demonstrated simultaneously, when a study of multilamellar liposomes containing rifampicin and isoniazid exhibited presence in alveolar macrophages and could maintain therapeutic concentrations in the lung tissue for 5 days [77].…”
Section: General Approaches For Targeting Pulmonary Delivery Of Macromentioning
confidence: 99%